financetom
Business
financetom
/
Business
/
Investors react to Biden pulling out of presidential race
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Investors react to Biden pulling out of presidential race
Jul 21, 2024 12:12 PM

NEW YORK (Reuters) - U.S. President Joe Biden ended his reelection campaign on Sunday after fellow Democrats lost faith in his mental acuity and ability to beat Donald Trump, leaving the presidential race in uncharted territory.

Here are comments from investors:

BRIAN JACOBSEN, CHIEF ECONOMIST, ANNEX WEALTH MANAGEMENT, BROOKFIELD, WI:

"This is a contest once again. If Biden stayed in, the odds would have increasingly tilted not only in favor of Trump winning, but of there being a Republican sweep. Now it's race again. The Trump-Trade will likely take a breather as investors reassess the odds of the outcome. That means small caps, financials, energy, and crypto could see a little pullback, but Trump still has the edge."

JACK MCINTYRE, PORTFOLIO MANAGER, GLOBAL FIXED INCOME, BRANDYWINE GLOBAL INVESTMENT MANAGEMENT:

"I think overall this is going to be at least temporarily positive for markets...It's probably going to be a positive for the bond market, especially given just where we are in the business cycle and more importantly, where we are with growth, inflation.

"I suspect that if this moves us toward getting divided government, that is a positive for the market."

JAMIE COX, MANAGING PARTNER, HARRIS FINANCIAL GROUP, RICHMOND, VA:

"The question of who is going to be the nominee is going to re-enter investors' minds in a very big way."

"Markets are going to be terribly volatile until the Democrat nominee is known. That will likely manifest itself through the dollar, creating volatility in fixed income and equities."

GINA BOLVIN, PRESIDENT OF BOLVIN WEALTH MANAGEMENT GROUP

"Biden stepping down is a whole new level of political uncertainty. This may be the catalyst for market volatility that is overdue."

RHONA O'CONNELL, HEAD OF MARKET ANALYSIS - EMEA & ASIA - STONEX, LONDON:

"My instinctive reaction is that everything in the short term remains up in the air, vis-a-vis the Democrat nomination, obviously. But it may well put some brakes on the Trump locomotive.

"As far as risk-off is concerned - tailwinds are stronger for gold, purely on this basis, than headwinds. Some uncertainty been taken away, by definition, as per above."

"At least it points to a stronger opposition, to which is what every democracy should strive."

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Form 8.3 - Dowlais Group PLC
Form 8.3 - Dowlais Group PLC
Sep 10, 2025
LONDON--(BUSINESS WIRE)--   FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of...
Kian-Backed SPATCO Energy Solutions Continues National Expansion with Acquisition of Excell Fueling Systems
Kian-Backed SPATCO Energy Solutions Continues National Expansion with Acquisition of Excell Fueling Systems
Sep 10, 2025
The acquisition adds commercial services to SPATCO’s Texas portfolio, rounding out the platform’s comprehensive suite of services in the state ATLANTA & CHARLOTTE, N.C.--(BUSINESS WIRE)-- Kian Capital-backed SPATCO Energy Solutions (“SPATCO”), a forward-thinking provider of innovative, turnkey infrastructure services solutions to the petroleum, environmental and EV market segments, has completed the acquisition of Excell Fueling Systems (“Excell”). This marks...
Kadimastem and NLS Pharmaceutics Announce Effectiveness of SEC Registration Statement in Connection with Proposed Merger
Kadimastem and NLS Pharmaceutics Announce Effectiveness of SEC Registration Statement in Connection with Proposed Merger
Sep 10, 2025
ZURICH and NESS ZIONA, Israel, Sept. 10, 2025 /PRNewswire/ -- NLS Pharmaceutics Ltd. (Nasdaq: NLSPW) (NLS), a Swiss clinical-stage biopharmaceutical company focused on central nervous system (CNS) disorders, and Kadimastem Ltd. ( KMSTF ) (Kadimastem ( KMSTF )), an advanced clinical-stage cell therapy company progressing treatments for neurodegenerative diseases and diabetes, today announced that the U.S. Securities and Exchange Commission (the...
Essa Pharma Inc. to Adjourn Special Meeting to September 29, 2025
Essa Pharma Inc. to Adjourn Special Meeting to September 29, 2025
Sep 10, 2025
Adjournment to provide time for continued discussions regarding possible revised financial terms of transaction with XenoTherapeutics SOUTH SAN FRANCISCO, Calif. and VANCOUVER, BC, Sept. 10, 2025 /PRNewswire/ -- ESSA Pharma Inc. (ESSA, or the Company) today announced that the Board of Directors of the Company has approved an adjournment of the special meeting of the holders of common shares of the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved